Global Antibody Drug Conjugate (ADC) Drug Market Insights and Forecast to 2028

Global Antibody Drug Conjugate (ADC) Drug Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mmunomedics Technology
1.2.3 Immunogen Technology
1.2.4 Seattle Genetics Technology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biotechnology Companies
1.3.3 Specialized Cancer Centers
1.3.4 Biopharmaceutical Companies
1.3.5 Academic Research Institutes
1.3.6 Hospitals
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antibody Drug Conjugate (ADC) Drug Market Perspective (2017-2028)
2.2 Antibody Drug Conjugate (ADC) Drug Growth Trends by Region
2.2.1 Antibody Drug Conjugate (ADC) Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antibody Drug Conjugate (ADC) Drug Historic Market Size by Region (2017-2022)
2.2.3 Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Region (2023-2028)
2.3 Antibody Drug Conjugate (ADC) Drug Market Dynamics
2.3.1 Antibody Drug Conjugate (ADC) Drug Industry Trends
2.3.2 Antibody Drug Conjugate (ADC) Drug Market Drivers
2.3.3 Antibody Drug Conjugate (ADC) Drug Market Challenges
2.3.4 Antibody Drug Conjugate (ADC) Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Revenue
3.1.1 Global Top Antibody Drug Conjugate (ADC) Drug Players by Revenue (2017-2022)
3.1.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2017-2022)
3.2 Global Antibody Drug Conjugate (ADC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Drug Conjugate (ADC) Drug Revenue
3.4 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio
3.4.1 Global Antibody Drug Conjugate (ADC) Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate (ADC) Drug Revenue in 2021
3.5 Antibody Drug Conjugate (ADC) Drug Key Players Head office and Area Served
3.6 Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
3.7 Date of Enter into Antibody Drug Conjugate (ADC) Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug Conjugate (ADC) Drug Breakdown Data by Type
4.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Type (2017-2022)
4.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Type (2023-2028)
5 Antibody Drug Conjugate (ADC) Drug Breakdown Data by Application
5.1 Global Antibody Drug Conjugate (ADC) Drug Historic Market Size by Application (2017-2022)
5.2 Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
6.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Type
6.2.1 North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
6.2.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
6.2.3 North America Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
6.3 North America Antibody Drug Conjugate (ADC) Drug Market Size by Application
6.3.1 North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
6.3.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
6.3.3 North America Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
6.4 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country
6.4.1 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
6.4.2 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type
7.2.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
7.2.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
7.2.3 Europe Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application
7.3.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
7.3.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
7.3.3 Europe Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
7.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country
7.4.1 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
7.4.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
8.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type
8.2.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application
8.3.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region
8.4.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
9.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type
9.2.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
9.2.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
9.2.3 Latin America Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
9.3 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application
9.3.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
9.3.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
9.3.3 Latin America Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
9.4 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country
9.4.1 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
9.4.2 Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size (2017-2028)
10.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type
10.2.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application
10.3.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country
10.4.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Oxford Bio Therapeutics
11.1.1 Oxford Bio Therapeutics Company Details
11.1.2 Oxford Bio Therapeutics Business Overview
11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.1.4 Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.1.5 Oxford Bio Therapeutics Recent Developments
11.2 Synthon
11.2.1 Synthon Company Details
11.2.2 Synthon Business Overview
11.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Introduction
11.2.4 Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.2.5 Synthon Recent Developments
11.3 Progenics Pharmaceuticals
11.3.1 Progenics Pharmaceuticals Company Details
11.3.2 Progenics Pharmaceuticals Business Overview
11.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
11.3.4 Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.3.5 Progenics Pharmaceuticals Recent Developments
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Details
11.4.2 Bayer HealthCare Business Overview
11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Introduction
11.4.4 Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.4.5 Bayer HealthCare Recent Developments
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Details
11.5.2 Millennium Pharmaceuticals Business Overview
11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Introduction
11.5.4 Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.5.5 Millennium Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Introduction
11.6.4 Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Concortis Bio therapeutics
11.7.1 Concortis Bio therapeutics Company Details
11.7.2 Concortis Bio therapeutics Business Overview
11.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.7.4 Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.7.5 Concortis Bio therapeutics Recent Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Details
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Introduction
11.8.4 Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.8.5 Roche Holding AG Recent Developments
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Details
11.9.2 Seattle Genetics Business Overview
11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Introduction
11.9.4 Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.9.5 Seattle Genetics Recent Developments
11.10 Heidelberg Pharma
11.10.1 Heidelberg Pharma Company Details
11.10.2 Heidelberg Pharma Business Overview
11.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Introduction
11.10.4 Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.10.5 Heidelberg Pharma Recent Developments
11.11 Mersana Therapeutics
11.11.1 Mersana Therapeutics Company Details
11.11.2 Mersana Therapeutics Business Overview
11.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.11.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.11.5 Mersana Therapeutics Recent Developments
11.12 Astellas Pharma/Agensys
11.12.1 Astellas Pharma/Agensys Company Details
11.12.2 Astellas Pharma/Agensys Business Overview
11.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Introduction
11.12.4 Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.12.5 Astellas Pharma/Agensys Recent Developments
11.13 AbbVie Inc
11.13.1 AbbVie Inc Company Details
11.13.2 AbbVie Inc Business Overview
11.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Introduction
11.13.4 AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.13.5 AbbVie Inc Recent Developments
11.14 Celldex Therapeutics
11.14.1 Celldex Therapeutics Company Details
11.14.2 Celldex Therapeutics Business Overview
11.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Introduction
11.14.4 Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.14.5 Celldex Therapeutics Recent Developments
11.15 Immunomedics
11.15.1 Immunomedics Company Details
11.15.2 Immunomedics Business Overview
11.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Introduction
11.15.4 Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.15.5 Immunomedics Recent Developments
11.16 Agensys
11.16.1 Agensys Company Details
11.16.2 Agensys Business Overview
11.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Introduction
11.16.4 Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.16.5 Agensys Recent Developments
11.17 Genentech
11.17.1 Genentech Company Details
11.17.2 Genentech Business Overview
11.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Introduction
11.17.4 Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.17.5 Genentech Recent Developments
11.18 ImmunoGen
11.18.1 ImmunoGen Company Details
11.18.2 ImmunoGen Business Overview
11.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Introduction
11.18.4 ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.18.5 ImmunoGen Recent Developments
11.19 Sanofi
11.19.1 Sanofi Company Details
11.19.2 Sanofi Business Overview
11.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Introduction
11.19.4 Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.19.5 Sanofi Recent Developments
11.20 Genmab
11.20.1 Genmab Company Details
11.20.2 Genmab Business Overview
11.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Introduction
11.20.4 Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.20.5 Genmab Recent Developments
11.21 Amgen
11.21.1 Amgen Company Details
11.21.2 Amgen Business Overview
11.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Introduction
11.21.4 Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.21.5 Amgen Recent Developments
11.22 Novartis
11.22.1 Novartis Company Details
11.22.2 Novartis Business Overview
11.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Introduction
11.22.4 Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.22.5 Novartis Recent Developments
11.23 Eli Lilly
11.23.1 Eli Lilly Company Details
11.23.2 Eli Lilly Business Overview
11.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Introduction
11.23.4 Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022)
11.23.5 Eli Lilly Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Mmunomedics Technology
Table 3. Key Players of Immunogen Technology
Table 4. Key Players of Seattle Genetics Technology
Table 5. Key Players of Others
Table 6. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Antibody Drug Conjugate (ADC) Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Antibody Drug Conjugate (ADC) Drug Market Share by Region (2017-2022)
Table 10. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Antibody Drug Conjugate (ADC) Drug Market Share by Region (2023-2028)
Table 12. Antibody Drug Conjugate (ADC) Drug Market Trends
Table 13. Antibody Drug Conjugate (ADC) Drug Market Drivers
Table 14. Antibody Drug Conjugate (ADC) Drug Market Challenges
Table 15. Antibody Drug Conjugate (ADC) Drug Market Restraints
Table 16. Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Players (2017-2022)
Table 18. Global Top Antibody Drug Conjugate (ADC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate (ADC) Drug as of 2021)
Table 19. Ranking of Global Top Antibody Drug Conjugate (ADC) Drug Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Antibody Drug Conjugate (ADC) Drug Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antibody Drug Conjugate (ADC) Drug Product Solution and Service
Table 23. Date of Enter into Antibody Drug Conjugate (ADC) Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type (2017-2022)
Table 27. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type (2023-2028)
Table 29. Global Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Application (2017-2022)
Table 31. Global Antibody Drug Conjugate (ADC) Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Application (2023-2028)
Table 33. North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 63. Oxford Bio Therapeutics Company Details
Table 64. Oxford Bio Therapeutics Business Overview
Table 65. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 66. Oxford Bio Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 67. Oxford Bio Therapeutics Recent Developments
Table 68. Synthon Company Details
Table 69. Synthon Business Overview
Table 70. Synthon Antibody Drug Conjugate (ADC) Drug Product
Table 71. Synthon Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 72. Synthon Recent Developments
Table 73. Progenics Pharmaceuticals Company Details
Table 74. Progenics Pharmaceuticals Business Overview
Table 75. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product
Table 76. Progenics Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 77. Progenics Pharmaceuticals Recent Developments
Table 78. Bayer HealthCare Company Details
Table 79. Bayer HealthCare Business Overview
Table 80. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product
Table 81. Bayer HealthCare Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 82. Bayer HealthCare Recent Developments
Table 83. Millennium Pharmaceuticals Company Details
Table 84. Millennium Pharmaceuticals Business Overview
Table 85. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product
Table 86. Millennium Pharmaceuticals Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 87. Millennium Pharmaceuticals Recent Developments
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Antibody Drug Conjugate (ADC) Drug Product
Table 91. Pfizer Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 92. Pfizer Recent Developments
Table 93. Concortis Bio therapeutics Company Details
Table 94. Concortis Bio therapeutics Business Overview
Table 95. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 96. Concortis Bio therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 97. Concortis Bio therapeutics Recent Developments
Table 98. Roche Holding AG Company Details
Table 99. Roche Holding AG Business Overview
Table 100. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product
Table 101. Roche Holding AG Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 102. Roche Holding AG Recent Developments
Table 103. Seattle Genetics Company Details
Table 104. Seattle Genetics Business Overview
Table 105. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product
Table 106. Seattle Genetics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 107. Seattle Genetics Recent Developments
Table 108. Heidelberg Pharma Company Details
Table 109. Heidelberg Pharma Business Overview
Table 110. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product
Table 111. Heidelberg Pharma Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 112. Heidelberg Pharma Recent Developments
Table 113. Mersana Therapeutics Company Details
Table 114. Mersana Therapeutics Business Overview
Table 115. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 116. Mersana Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 117. Mersana Therapeutics Recent Developments
Table 118. Astellas Pharma/Agensys Company Details
Table 119. Astellas Pharma/Agensys Business Overview
Table 120. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product
Table 121. Astellas Pharma/Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 122. Astellas Pharma/Agensys Recent Developments
Table 123. AbbVie Inc Company Details
Table 124. AbbVie Inc Business Overview
Table 125. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product
Table 126. AbbVie Inc Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 127. AbbVie Inc Recent Developments
Table 128. Celldex Therapeutics Company Details
Table 129. Celldex Therapeutics Business Overview
Table 130. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product
Table 131. Celldex Therapeutics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 132. Celldex Therapeutics Recent Developments
Table 133. Immunomedics Company Details
Table 134. Immunomedics Business Overview
Table 135. Immunomedics Antibody Drug Conjugate (ADC) Drug Product
Table 136. Immunomedics Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 137. Immunomedics Recent Developments
Table 138. Agensys Company Details
Table 139. Agensys Business Overview
Table 140. Agensys Antibody Drug Conjugate (ADC) Drug Product
Table 141. Agensys Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 142. Agensys Recent Developments
Table 143. Genentech Company Details
Table 144. Genentech Business Overview
Table 145. Genentech Antibody Drug Conjugate (ADC) Drug Product
Table 146. Genentech Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 147. Genentech Recent Developments
Table 148. ImmunoGen Company Details
Table 149. ImmunoGen Business Overview
Table 150. ImmunoGen Antibody Drug Conjugate (ADC) Drug Product
Table 151. ImmunoGen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 152. ImmunoGen Recent Developments
Table 153. Sanofi Company Details
Table 154. Sanofi Business Overview
Table 155. Sanofi Antibody Drug Conjugate (ADC) Drug Product
Table 156. Sanofi Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 157. Sanofi Recent Developments
Table 158. Genmab Company Details
Table 159. Genmab Business Overview
Table 160. Genmab Antibody Drug Conjugate (ADC) Drug Product
Table 161. Genmab Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 162. Genmab Recent Developments
Table 163. Amgen Company Details
Table 164. Amgen Business Overview
Table 165. Amgen Antibody Drug Conjugate (ADC) Drug Product
Table 166. Amgen Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 167. Amgen Recent Developments
Table 168. Novartis Company Details
Table 169. Novartis Business Overview
Table 170. Novartis Antibody Drug Conjugate (ADC) Drug Product
Table 171. Novartis Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 172. Novartis Recent Developments
Table 173. Eli Lilly Company Details
Table 174. Eli Lilly Business Overview
Table 175. Eli Lilly Antibody Drug Conjugate (ADC) Drug Product
Table 176. Eli Lilly Revenue in Antibody Drug Conjugate (ADC) Drug Business (2017-2022) & (US$ Million)
Table 177. Eli Lilly Recent Developments
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Drug Conjugate (ADC) Drug Market Share by Type: 2021 VS 2028
Figure 2. Mmunomedics Technology Features
Figure 3. Immunogen Technology Features
Figure 4. Seattle Genetics Technology Features
Figure 5. Others Features
Figure 6. Global Antibody Drug Conjugate (ADC) Drug Market Share by Application: 2021 VS 2028
Figure 7. Biotechnology Companies Case Studies
Figure 8. Specialized Cancer Centers Case Studies
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Academic Research Institutes Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 14. Global Antibody Drug Conjugate (ADC) Drug Market Size (US$ Million), Year-over-Year: 2

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs